MARROSU, FRANCESCO
 Distribuzione geografica
Continente #
EU - Europa 361.270
NA - Nord America 20.367
AS - Asia 8.228
SA - Sud America 1.160
Continente sconosciuto - Info sul continente non disponibili 649
AF - Africa 162
OC - Oceania 34
Totale 391.870
Nazione #
IT - Italia 355.554
US - Stati Uniti d'America 20.041
SG - Singapore 3.125
CN - Cina 3.058
UA - Ucraina 1.417
SE - Svezia 1.161
BR - Brasile 917
DE - Germania 766
FI - Finlandia 732
VN - Vietnam 663
GB - Regno Unito 548
FR - Francia 481
HK - Hong Kong 282
IN - India 195
CA - Canada 184
KR - Corea 149
NL - Olanda 140
BD - Bangladesh 130
JP - Giappone 92
AR - Argentina 85
IQ - Iraq 83
RU - Federazione Russa 77
MX - Messico 62
PL - Polonia 62
PK - Pakistan 59
TR - Turchia 56
ES - Italia 54
AT - Austria 43
UZ - Uzbekistan 42
CH - Svizzera 41
BE - Belgio 39
IR - Iran 36
ZA - Sudafrica 34
MA - Marocco 33
ID - Indonesia 32
VE - Venezuela 31
CO - Colombia 30
IE - Irlanda 28
EC - Ecuador 27
PH - Filippine 27
AU - Australia 26
AE - Emirati Arabi Uniti 22
EU - Europa 22
SA - Arabia Saudita 22
AZ - Azerbaigian 20
CL - Cile 20
KE - Kenya 20
IL - Israele 19
JM - Giamaica 19
JO - Giordania 17
TN - Tunisia 17
CZ - Repubblica Ceca 16
PY - Paraguay 16
TH - Thailandia 15
BO - Bolivia 13
CU - Cuba 13
MY - Malesia 13
LT - Lituania 12
PT - Portogallo 11
UY - Uruguay 11
TW - Taiwan 10
BG - Bulgaria 9
DO - Repubblica Dominicana 9
RO - Romania 9
SI - Slovenia 9
CR - Costa Rica 8
EG - Egitto 8
LB - Libano 8
MD - Moldavia 8
PE - Perù 8
DZ - Algeria 7
ET - Etiopia 7
NZ - Nuova Zelanda 7
OM - Oman 7
PA - Panama 7
DK - Danimarca 6
GR - Grecia 6
GT - Guatemala 6
HN - Honduras 6
HR - Croazia 6
KZ - Kazakistan 6
LK - Sri Lanka 6
MU - Mauritius 6
AL - Albania 5
EE - Estonia 5
GE - Georgia 5
LU - Lussemburgo 5
NG - Nigeria 5
NP - Nepal 5
TT - Trinidad e Tobago 5
AO - Angola 4
BY - Bielorussia 4
HU - Ungheria 4
MK - Macedonia 4
PS - Palestinian Territory 4
SV - El Salvador 4
CY - Cipro 3
GA - Gabon 3
KG - Kirghizistan 3
LV - Lettonia 3
Totale 391.200
Città #
Cagliari 348.184
Uta 5.169
Fairfield 1.686
Ashburn 1.669
Woodbridge 1.597
Singapore 1.485
Chandler 1.412
San Jose 1.118
Houston 988
Boardman 910
Ann Arbor 865
Dallas 836
Wilmington 777
Nyköping 761
Jacksonville 730
Seattle 646
Beijing 586
Dearborn 567
Cambridge 546
Helsinki 480
Los Angeles 358
Nanjing 287
New York 277
Santa Clara 263
Council Bluffs 261
Lauterbourg 234
Hong Kong 232
Munich 223
Shanghai 222
The Dalles 217
Rome 210
Boston 207
Milan 202
Hefei 195
Ho Chi Minh City 191
Hanoi 138
Seoul 137
Buffalo 136
San Diego 112
Shenyang 103
Guangzhou 91
Nanchang 87
Orem 87
São Paulo 86
Toronto 79
Redwood City 78
Dong Ket 72
Hebei 72
London 71
Jiaxing 68
Tianjin 64
Verona 62
Atlanta 59
Changsha 59
Norwalk 58
Chicago 55
Frankfurt am Main 50
Sassari 50
Tokyo 49
Phoenix 46
Warsaw 46
Redondo Beach 44
Montreal 43
Brooklyn 42
Mountain View 42
Jinan 41
San Francisco 41
Chennai 40
Tashkent 37
Brussels 36
Da Nang 36
Stockholm 35
Orange 34
Washington 34
Amsterdam 33
Naples 33
Rio de Janeiro 32
Wuhan 30
Zhengzhou 30
Baghdad 29
Denver 29
Kunming 29
Columbus 28
Ningbo 28
Pune 28
Haiphong 27
Manchester 27
Leawood 25
Nuremberg 25
Dublin 23
Florence 23
Auburn Hills 22
Hangzhou 22
Mumbai 22
Porto Alegre 22
Augusta 21
San Mateo 21
Turin 21
Falls Church 20
Mexico City 20
Totale 377.781
Nome #
Mucuna pruriens (Velvet bean) Rescues Motor, Olfactory, Mitochondrial and Synaptic Impairment in PINK1(B9) Drosophila melanogaster Genetic Model of Parkinson's Disease 5.438
Drosophila model for parkinson’s disease: function, anatomy and screening with phytoterapics from Sardinian and Indian flora (Withania somnifera and Mucuna pruriens) 5.083
Functional and morphological correlates in the drosophila LRRK2 loss-of-function model of Parkinson's disease: drug effects of Withania somnifera (Dunal) administration 5.025
VGF protein and its C-terminal derived peptides in amyotrophic lateral sclerosis: Human and animal model studies 4.788
Differential effects of phytotherapic preparations in the hSOD1 Drosophila melanogaster model of ALS 4.324
C9ORF72 intermediate repeat expansion in patients affected by atypical Parkinsonian syndromes or parkinson’s disease complicated by psychosis or dementia in a Sardinian population 4.292
PROP bitter taste-induced brain activation-deactivation in gustatory signal processing: a functional magnetic resonance imaging (fMRI) study 4.201
The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson's disease 4.087
OLFACTORY DYSFUNCTION AS POTENTIAL BIOMARKER IN NEURODEGENERATIVE DISORDERS 4.045
The neurosteroidogenic enzyme 5α-reductase mediates psychotic-like complications of sleep deprivation 3.924
Drosophila mutant model of Parkinson's disease revealed an unexpected olfactory performance: Morphofunctional evidences 3.870
Morningness Eveningness Questionnaire (MEQ) and salivary DLMO determination: a reliable method of evaluation for circadian pattern 3.734
Impaired sense of smell in a Drosophila Parkinson's model. 3.671
Metabolomics as a Tool for the characterization of Drug-resistant epilepsy 3.547
Brain activation pattern during perception of PROP bitter taste using functional magnetic resonance imaging (fMRI) 3.534
Drosophila Parkinson's mutant display olfactory impairment both to natural and synthetic compounds 3.515
Heart rate variability shows different cardiovascular modulation in Parkinson's disease patients with tremor dominant subtype compared to those with akinetic rigid dominant subtype 3.479
The re-organization of functional brain networks in pharmaco-resistant epileptic patients who respond to VNS 3.436
F-Wave duration as a specific and sensitive tool for the diagnosis of restless legs syndrome/Willis-Ekbom disease 3.428
VNS induced desynchronization in gamma bands correlates with positive clinical outcome in temporal lobe pharmacoresistant epilepsy 3.406
A multimodal neuroimaging approach in patients with early diagnosis of Parkinson's disease: Correlations between f-MRI with fine motor tasks, EEG and clinical tests 3.273
Parkinsonism and dementia are negative prognostic factors for the outcome of subdural hematoma 3.264
EEG functional network topology is associated with disability in patients with amyotrophic lateral sclerosis 3.243
Pisa-Like Syndrome Under Baclofen in a Patient With Spastic Hemiparesis due to Ischemic Stroke 3.185
A genetic study of the FMR1 gene in a Sardinian multiple sclerosis population 3.124
Focal 123I-FP-CIT SPECT abnormality in a patient with midbrain vascular Parkinsonism 3.103
PPAR-alpha agonists as novel antiepileptic drugs: preclinical findings 2.963
TLQP peptides in amyotrophic lateral sclerosis: possible blood biomarkers with a neuroprotective role 2.946
An unusual delusion of duplication in a patient affected by Dementia with Lewy bodies 2.944
Involvement of GABA in mirror focus: A case report 2.942
Influence of parkinsonism on Hitler's decision-making 2.918
Functional brain connectivity analysis in amyotrophic lateral sclerosis: an EEG source-space study 2.917
The effect of epoch length on estimated EEG functional connectivity and brain network organisation 2.838
VGF peptides as novel biomarkers in Parkinson’s disease 2.824
Polimorfismo Val66Met e valori di BDNF in pazienti affetti da epilessia farmacoresistente trattati con stimolazione del nervo vago (VNS). 2.792
Imaging and Genomic Classification of Brain Alteration Induced By Gustatory Bitter Stimulus, A Pilot Study 2.722
Changes in MEG resting-state networks are related to cognitive decline in type 1 diabetes mellitus patients 2.720
C9ORF72 repeat expansion and bipolar disorder–is there a link? No mutation detected in a Sardinian cohort of patients with bipolar disorder 2.681
Networks in the brain: from neurovascular coupling of the BOLD effect to brain functional architecture 2.675
Inhibition of 5 alpha-reductase in the nucleus accumbens counters sensorimotor gating deficits induced by dopaminergic activation 2.611
New vistas on VNS mechanism of action 2.608
Overlap Parasomnia Disorder in a case of Creutzfeldt-Jakob Disease 2.602
Reduction of fat mass by vagus nerve stimulation in rats 2.564
Vagus Nerve Stimulation Reduces Body Weight and Fat Mass in Rats 2.556
Cerebellar continuous theta burst stimulation reduces levodopa-induced dyskinesias and decreases serum BDNF levels 2.545
Dopamine dysregulation syndrome in Parkinson's disease patients on levodopa-carbidopa intestinal gel 2.505
Reduced serum level of THDOC, an anticonvulsant steroid, in women with perimenstrual catamenial epilepsy 2.452
Clinical and genetic characteristics of late-onset Huntington's disease 2.417
Graph theory-based analysis of EEG during nREM sleep reveals changes in functional connectivity in sleep-related hypermotor epilepsy (SHE) 2.414
null 2.394
Defective cerebral gamma-aminobutyric acid-A receptor density in patients with systemic lupus erythematosus and central nervous system involvement. An observational study 2.365
PPAR-alpha: a new target for the treatment of nocturnal frontal lobe epilepsy 2.361
Brain MRI and SPECT in the diagnosis of early neurological involvement in Wilson's disease 2.348
Blockade of 5-alpha reductase reduces compulsive behaviors in mice 2.319
Study of autonomic cardiovascular dysfunction in Parkinson’s disease patients with LRRK2 mutations using Heart Rate Variability 2.313
Clinical manifestations of intermediate allele carriers in Huntington disease 2.288
Specificity and sensitivity of F-waves parameters in diagnosis of RLS/WED 2.234
Study on the correlation among total burden of nonmotor symptoms and cardiovascular dysmodulation in Parkinson’s disease patients 2.222
Sleep motor activity in amyotrophic lateral sclerosis 2.203
Effects of vagus nerve stimulation on BDNF gene expression and hippocampal plasticity in the rat 2.182
Occurence and DAergic therapy correlates of REM sleep behavior disorder in patients with Parkinson Disease 2.173
Autonomic imbalance in Parkinson's disease patients with or without LRRK2 gene mutations 2.167
Activation of GABA(B) receptors reverses spontaneous gating deficits in juvenile DBA/2J mice 2.155
Neuroimaging, Networking and Systems Biology: The New Way to Investigate Pathologies with Neurological System Implications. The example of Tourette Syndrome as a Pilot Study 2.153
Chronic vagus nerve stimulation induces neuronal plasticity in the rat hippocampus 2.152
Suicide and Dopamine Agonist Withdrawal Syndrome in Parkinson's Disease 2.129
Increase in 20-50 Hz (gamma frequencies) power spectrum and synchronization after chronic vagal nerve stimulation 2.106
How individual habits fit/unfit social norms: from the historical perspective to a neurobiological repositioning of an unresolved problem 2.085
Relationship of morningness-eveningness questionnaire score to Melatonin DLMO measured from saliva sample: circadian patterns of a normal subjects group and a delayed phase syndrome 2.080
Genetic analysis for five LRRK2 mutations in a Sardinian parkinsonian population: Importance of G2019S and R1441C mutations in sporadic Parkinson’s disease patients 2.070
Reversible Pisa syndrome in patients with Parkinson's disease on dopaminergic therapy 2.024
Assessment of heart rate variability in a population of Sardinian patients affected by amyotrophic lateral sclerosis 2.015
A multivariate approach for the brain impairment in patients with liver cirrhosi 2.000
Chronic effects of vagus nerve stimulation on body fat mass in the rat 1.981
Reduction in rat body weight and fat mass without affecting food intake induced by vagus nerve stimulation 1.956
Association between fatigue and other motor and non-motor symptoms in Parkinson's disease patients 1.930
null 1.926
ECG-based cardiopulmonary coupling for sleep stability assessment in patients with amyotrophic lateral sclerosis 1.920
Isolated rapid eye movement sleep without atonia in amyotrophic lateral sclerosis 1.911
Bipolar affective disorder preceding frontotemporal dementia in a patient with C9ORF72 mutation: is there a genetic link between these two disorders? 1.896
Loss of heart rate variability in ALS: Time and frequency domain assessment. 1.893
Parkin exon rearrangements and sequence variants in LRRK2 mutations carriers: analysis on a possible modifier effects on LRRK2 penetrance 1.892
Discordance between Dopamine transporter deficit and motor symptoms in a case of REM sleep behavior disorder 1.891
Vagal nerve stimulation effects on cerebellar tremor in multiple sclerosis 1.877
The implication of neuroactive steroids in tourette's syndrome pathogenesis: A role for 5α-reductase? 1.870
Dissociation Between Neurovegetative Signs and Subjective Symptoms in a Case of Idiopathic Pilomotor Seizures 1.848
EEG spectral coherence analysis in nocturnal epilepsy 1.818
Role of DA-ergic therapy on REM sleep behaviour disorder in a large population of Parkinsonians 1.801
Spectral coherence analysis in EEG nocturnal epilepsy recordings 1.774
Lack of antidepressant like behavioral effects of chronic vagus nerve stimulation in the rat despite neurochemical end molecular antidepressant like effects 1.766
Respiratory sleep disorders in Jeune syndrome: a case description 1.758
Facial synkinesis as a first symptom of multiple sclerosis 1.755
Long-latency potential study in minimal hepatic hencephalopaty 1.751
Motor sleep features in a Sardinian population of amyotrophic lateral sclerosis patients. 1.713
Vagal nerve stimulation effects on cerebellar tremor in multiple sclerosis 1.693
Leucine-rich repeat kinase 2 (LRRK2) gene mutations in degenerative parkinsonism 1.689
Prevalence of Huntington's disease in Southern Sardinia, Italy 1.653
Long term vagus nerve stimulation (VNS) modifies EEG coherences and frequency power spectrum in partial epilepsy 1.643
Isolation rearing-induced reduction of brain 5 alpha-reductase expression: Relevance to dopaminergic impairments 1.627
Geographic differences in the incidence of Huntington's disease in Sardinia, Italy 1.603
Totale 263.548
Categoria #
all - tutte 500.989
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 500.989


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202215.211 0 1.464 1.074 1.207 1.687 1.290 929 845 1.349 1.629 1.749 1.988
2022/202322.973 2.139 3.064 2.767 2.045 1.897 2.202 1.185 1.859 1.392 1.404 1.886 1.133
2023/202423.308 1.418 1.098 1.041 1.628 2.416 3.625 3.391 1.643 1.066 1.732 2.049 2.201
2024/202536.739 6.047 8.461 4.798 4.104 4.331 2.595 3.373 391 811 571 506 751
2025/202615.295 908 623 1.648 1.348 1.312 1.464 2.208 1.038 1.369 1.699 917 761
2026/20271.208 716 492 0 0 0 0 0 0 0 0 0 0
Totale 391.870